시장보고서

상품코드

1515603

암 악액질 시장 : 요법별, 작용기서별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Cancer Cachexia Market, By Therapeutics, By Mechanism of Action, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 06월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 288 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

암 악액질 시장 규모는 2023년에 32억 2,832만 달러로 평가되며, 2024-2032년 CAGR 5.90%로 확대

암성 악액질 시장 - 시장 역학

암 부담 증가가 시장 수요를 촉진합니다.

세계의 암 부담이 증가함에 따라 국가와 지역의 우선순위에 따라 암 치료의 변화가 필요하며, 2020년 12월 국제암연구소(IARC)에 따르면 전 세계 5명 중 1명이 일생 동안 암에 걸리며, 여성 11명 중 1명, 남성 8명 중 1명이 암으로 사망할 것으로 예상됩니다. 2022년 2월 발표된 WHO 자료에 따르면 연간 약 40만 명의 어린이가 암에 걸리며, 가장 많이 발생하는 유형은 국가마다 다릅니다. 예를 들어 자궁경부암은 23개국에서 가장 많습니다. 전 세계에서 암 발병률이 증가함에 따라 암성 악액질 유병률도 증가하고 있습니다. 이 악액질은 단백질과 에너지의 부정적 균형, 전신 염증, 비자발적 제지방 체중 감소를 특징으로 합니다. 암성 악액질 및 암 유병률 증가는 새로운 암성 악액질 치료를 위한 연구개발 투자 증가와 함께 시장 성장을 가속하는 주요 요인으로 작용하고 있습니다.

암 악액질 시장 - 주요 인사이트

AnalystView Market Insights의 리서치 분석가들의 분석에 따르면 세계 시장은 예측 기간(2024-2032년) 동안 연평균 약 5.90%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예상됩니다.

치료법 세분화에 따라 2023년에는 프로게스토겐이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.

작용 메커니즘 세분화에 따르면 2023년 식욕 자극제가 주요 유형으로 부상할 것으로 예상됩니다.

지역별로는 북미가 2023년 매출에서 선두를 차지했습니다.

암 악액질 시장 - 세분화 분석 :

세계 암 악액질 시장은 크게 치료제, 작용기전, 용도, 지역에 따라 세분화됩니다.

시장은 치료제를 기준으로 황체 호르몬, 부신피질 호르몬, 병용 요법, 기타 등 4가지 범주로 나뉩니다. 프로게스토겐 부문은 암성 악액질 치료에 있으며, 저비용과 고효율로 인해 2023년 압도적인 시장 점유율을 차지할 것으로 예상됩니다.

시장은 작용기전에 따라 크게 식욕촉진제와 체중감량 안정제의 두 가지 범주로 나뉩니다. 작용기전별로 보면 식욕촉진제가 암성 악액질 시장을 장악하고 크게 성장할 것으로 예상됩니다. 암 환자들은 종종 식욕 부진과 의도하지 않은 체중 감소를 경험하는데, 이는 환자의 수행 능력 저하, 치료에 대한 반응과 내성 감소, 생존율 감소, 삶의 질 저하로 이어집니다. 따라서 식욕이 저하된 환자에게 식욕 증진제 사용이 고려되고 있습니다. 암성 악액질 유병률 증가는 시장 성장을 가속하는 주요 요인입니다.

암 악액질 시장 - 지역적 인사이트

지역적 관점에서 볼 때, 이 시장은 유럽, 북미, 라틴아메리카, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 이 지역은 참여 국가에 따라 더 세분화됩니다. 북미는 암 및 암 악액질에 대한 높은 부담, 다수의 제약사 존재, 암 환자 치료의 발전 등으로 인해 시장을 주도할 것으로 예상되며, GLOBOCAN 2020의 추정에 따르면 멕시코에서 약 195,499명의 신규 암 환자가 보고된 것으로 나타났습니다. 보고되고 있습니다. 또한 미국암협회는 2022년 미국에서 약 190만 명의 암 환자가 새로 진단될 것으로 예상하고 있습니다.

암 악액질 시장 - 경쟁상황 :

암성 악액질 시장은 통합되어 있으며, 전 세계 및 지역에서 사업을 운영하는 주요 기업은 몇 개로 제한되어 있습니다. 이들 주요 기업은 주로 암성 악액질 치료를 위한 효능이 높은 신약 연구개발에 집중하고 있으며, 그 결과 승인 및 상업적 출시를 기다리는 치료제 파이프라인이 증가하고 있습니다. 진행 중이거나 진행 중인 150건의 연구를 보고하고 있습니다. 예를 들어 2020년 12월 코펜하겐 대학은 뉴질랜드 대학병원과 공동으로 옥살리플라틴 또는 파클리탁셀 기반 화학요법을 받는 환자의 제지방 체중(악액질)에 대한 의료용 칸나비디올의 효과를 모니터링하는 연구를 시작했습니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석 - 암 악액질 업계

경쟁 대시보드
기업 개요
- Aeterna Zentaris
- Aphios Corporation
- Bristol-Myers Squibb Company
- Pfizer Inc.
- Helsinn Group
- Merck KGaA
- Artelo Biosciences Inc.
- NGM Biopharmaceuticals
- Aveo Oncology
- Aavogen Inc.
- Green Cross Wellbeing Corporation
- Cannabics Pharmaceuticals Inc.
- TCI Peptide Therapeutics
- Fresenius Kabi
- Tetra Bio-Pharma
- Actimed Therapeutics
- Others

제12장 애널리스트의 전방위 전망

KSA 24.07.26

REPORT HIGHLIGHT

Cancer Cachexia Market size was valued at USD 3,228.32 Million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.

Cancer cachexia presents as a multifaceted metabolic syndrome frequently observed in patients with advanced stages of malignancy. Characterized by involuntary weight loss, skeletal muscle wasting, fatigue, and anorexia, this syndrome transcends the limitations of inadequate dietary intake. Underlying mechanisms encompass systemic inflammation, metabolic aberrations, and the host's response to tumor-derived factors. Despite advancements in oncological therapies, cancer cachexia remains a formidable challenge, significantly impacting both the treatment outcomes and quality of life for affected individuals.

Cancer Cachexia Market- Market Dynamics

Rising cancer burden to propel market demand

The global cancer burden is rising, necessitating the modification of cancer therapies according to national and regional priorities. According to the (IARC) International Agency for Research on Cancer in December 2020, 1 in 5 people globally will develop cancer during their lifetime, with 1 in 11 women and 1 in 8 men dying from the disease. Data from the WHO, published in February 2022, indicates that approximately 400,000 children develop cancer annually, with the most common types varying by country. For instance, cervical cancer is the most prevalent in 23 countries. The increasing global cancer burden also raises the prevalence of cancer cachexia, characterized by negative protein and energy balance, systemic inflammation, and involuntary loss of lean body mass. The growing prevalence of cancer cachexia, and cancer along with increased investment in R&D for novel cancer cachexia treatments, are major factors driving market growth.

Cancer Cachexia Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2024-2032)

Based on Therapeutics segmentation, progestogens were predicted to show maximum market share in the year 2023

Based on the mechanism of action segmentation, appetite stimulators were the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Cancer Cachexia Market- Segmentation Analysis:

The Global Cancer Cachexia Market is broadly segmented on the basis of Therapeutics, Mechanism of Action, Application, and Region.

The market is divided into four categories based on Therapeutics: progestogens, corticosteroids, combination therapies, and others. The progestogens segment held a dominant market share in 2023, due to their lower cost and high efficiency in treating cancer cachexia.

The market is broadly divided into two categories based on mechanism of action: Appetite Stimulators and Weight Loss Stabilizers. By mechanism of action, appetite stimulators are expected to dominate and grow significantly in the cancer cachexia market. Cancer patients often experience sort of appetite loss and unintended weight loss, which are linked to decreased performance status, reduced response and tolerance to treatment, decreased survival, and diminished quality of life. Therefore, the use of appetite stimulants is increasingly considered for patients with reduced appetite. The rising prevalence of cancer cachexia is a major factor driving the market's growth.

Cancer Cachexia Market- Geographical Insights

From a geographical perspective, this market extends across Europe, North America, Latin America, Asia Pacific, and the Middle East and Africa. These regions are further segmented based on the participating nations. North America is expected to lead the market, driven by the high burden of cancer and cancer cachexia, the presence of numerous drug manufacturers, and advancements in cancer patient care. According to GLOBOCAN 2020 estimates, Mexico reported around 195,499 new cancer cases. Additionally, the American Cancer Society projected approximately 1.9 million new cancer cases would be diagnosed in the United States in 2022.

Cancer Cachexia Market- Competitive Landscape:

The cancer cachexia market is consolidated, with only a few major companies operating globally and regionally. These key players are primarily focused on R&D to develop highly effective novel drugs for treating cancer cachexia, resulting in a growing pipeline of therapeutics awaiting approval and commercial launch. As of October 2022, clinicaltrials.gov reported 150 studies either conducted or ongoing to develop drugs for cancer cachexia. For instance, in December 2020, the University of Copenhagen, in collaboration with Zealand University Hospital, initiated a study to monitor the effect of the medical cannabidiol on the lean body mass (cachexia) in patients receiving Oxaliplatin- or Paclitaxel-based chemotherapy.

Recent Developments:

In January 2021, Helsinn Group and Ono Pharmaceutical Co. Ltd received approval in Japan to manufacture and market Adlumiz, a ghrelin receptor agonist for treating cancer cachexia in the patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, or colorectal cancer. Therefore, increasing research and development activities in the field are expected to drive market growth.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER CACHEXIA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Aeterna Zentaris

Aphios Corporation

Bristol-Myers Squibb Company

Pfizer Inc.

Helsinn Group

Merck KGaA

Artelo Biosciences Inc.

NGM Biopharmaceuticals

Aveo Oncology

Aavogen Inc.

Green Cross Wellbeing Corporation

Cannabics Pharmaceuticals Inc.

TCI Peptide Therapeutics

Fresenius Kabi

Tetra Bio-Pharma

Actimed Therapeutics

Others

GLOBAL CANCER CACHEXIA MARKET, BY THERAPEUTICS - MARKET ANALYSIS, 2019 - 2032

Progestogens
Corticosteroids
Combination Therapy
Other Therapeutics

GLOBAL CANCER CACHEXIA MARKET, BY MECHANISM OF ACTION- MARKET ANALYSIS, 2019 - 2032

Appetite Stimulators
Weight Loss Stabilizers

GLOBAL CANCER CACHEXIA MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

GLOBAL CANCER CACHEXIA MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Cancer Cachexia Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Cancer Cachexia Market Snippet by Therapeutics
- 2.1.2. Cancer Cachexia Market Snippet by Mechanism of Action
- 2.1.3. Cancer Cachexia Market Snippet by Application
- 2.1.4. Cancer Cachexia Market Snippet by Country
- 2.1.5. Cancer Cachexia Market Snippet by Region
2.2. Competitive Insights

3. Cancer Cachexia Key Market Trends

3.1. Cancer Cachexia Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Cancer Cachexia Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Cancer Cachexia Market Opportunities
3.4. Cancer Cachexia Market Future Trends

4. Cancer Cachexia Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Cancer Cachexia Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Cancer Cachexia Market Landscape

6.1. Cancer Cachexia Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Cancer Cachexia Market - By Therapeutics

7.1. Overview
- 7.1.1. Segment Share Analysis, By Therapeutics, 2023 & 2032 (%)
- 7.1.2. Progestogens
- 7.1.3. Corticosteroids
- 7.1.4. Combination Therapy
- 7.1.5. Other Therapeutics

8. Cancer Cachexia Market - By Mechanism of Action

8.1. Overview
- 8.1.1. Segment Share Analysis, By Mechanism of Action, 2023 & 2032 (%)
- 8.1.2. Appetite Stimulators
- 8.1.3. Weight Loss Stabilizers

9. Cancer Cachexia Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2. Hospital Pharmacy
- 9.1.3. Retail Pharmacy
- 9.1.4. Online Pharmacy

10. Cancer Cachexia Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Cancer Cachexia Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Cancer Cachexia Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Cancer Cachexia Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Cancer Cachexia Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Cancer Cachexia Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cancer Cachexia Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Aeterna Zentaris
- 11.2.2. Aphios Corporation
- 11.2.3. Bristol-Myers Squibb Company
- 11.2.4. Pfizer Inc.
- 11.2.5. Helsinn Group
- 11.2.6. Merck KGaA
- 11.2.7. Artelo Biosciences Inc.
- 11.2.8. NGM Biopharmaceuticals
- 11.2.9. Aveo Oncology
- 11.2.10. Aavogen Inc.
- 11.2.11. Green Cross Wellbeing Corporation
- 11.2.12. Cannabics Pharmaceuticals Inc.
- 11.2.13. TCI Peptide Therapeutics
- 11.2.14. Fresenius Kabi
- 11.2.15. Tetra Bio-Pharma
- 11.2.16. Actimed Therapeutics
- 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us